Literature DB >> 15785075

Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.

C Faleiro-Rodrigues1, I M Macedo-Pinto, S S Maia, R H Vieira, C S Lopes.   

Abstract

This study analysed the biological relevance of E-cadherin, alpha-catenin, beta-catenin and gamma-catenin immunoexpression pattern (reduced vs. preserved phenotype) in epithelial ovarian tumours. Immunohistochemistry was used to evaluate the expression of these proteins in 154 epithelial ovarian tumours, consisting of 17 benign, 33 borderline and 104 malignant tumours. In borderline tumours, the immunoexpression pattern of E-cadherin (p = 0.014) and alpha-catenin (p = 0.030) associated with histological type. In malignant tumours, the immunoexpression pattern of E-cadherin was related with histological type (p = 0.001). The immunoexpression pattern of beta-catenin associated with histological type and tumour differentiation (p = 0.005, p = 0.025, respectively). The preserved phenotype of E-cadherin was most frequently observed in mucinous tumours, whereas reduced E-cadherin was most frequently observed in serous tumours. The preserved phenotype of beta-catenin associated with endometrioid carcinomas, while reduced beta-catenin associated with poorly differentiated serous and clear cell carcinomas. Although the reduced phenotype was the most frequent immunoexpression observed for all proteins of the E-cadherin-catenin complex in epithelial ovarian tumours, only beta-catenin showed a significant difference between benign, borderline and malignant tumours (p = 0.045), since borderline and malignant tumours most frequently showed the reduced phenotype. The immunohistochemical profile of beta-catenin was shown to be of biological relevance: reduced beta-catenin was correlated with loss of tumour differentiation and serous carcinomas that are known to depict aggressive biological behaviour in epithelial ovarian tumours. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785075     DOI: 10.1159/000084614

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

1.  Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer.

Authors:  Yu Yuecheng; Li Hongmei; Xin Xiaoyan
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

Review 2.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

3.  Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.

Authors:  Rahul Bhagat; C S Premalata; V Shilpa; V R Pallavi; G Ramesh; C R Vijay; Lakshmi Krishnamoorthy
Journal:  Tumour Biol       Date:  2013-04-19

4.  Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.

Authors:  R Mitchell Baldwin; Alan Morettin; Genevieve Paris; Isabelle Goulet; Jocelyn Côté
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

5.  Serine protease modulation of Dependence Receptors and EMT protein expression.

Authors:  Kara McNair; Caroline M Forrest; Maria C J Vincenten; L Gail Darlington; Trevor W Stone
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

6.  Genome-wide analysis of DNA Methylation profiles on sheep ovaries associated with prolificacy using whole-genome Bisulfite sequencing.

Authors:  Yanli Zhang; Fengzhe Li; Xu Feng; Hua Yang; Aoxiang Zhu; Jing Pang; Le Han; Tingting Zhang; Xiaolei Yao; Feng Wang
Journal:  BMC Genomics       Date:  2017-10-02       Impact factor: 3.969

7.  Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.

Authors:  Hanna Karvonen; Mariliina Arjama; Laura Kaleva; Wilhelmiina Niininen; Harlan Barker; Riitta Koivisto-Korander; Johanna Tapper; Päivi Pakarinen; Heini Lassus; Mikko Loukovaara; Ralf Bützow; Olli Kallioniemi; Astrid Murumägi; Daniela Ungureanu
Journal:  Cell Death Dis       Date:  2020-09-23       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.